1,651
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Normobaric hyperoxygenation: a potential neuroprotective therapy for acute ischemic stroke?

, , &
 

Declaration of interest

SP is the coordinating investigator of the PROOF trial. JCB is the national co-coordinator for the French centres of the PROOF trial. ABS is on the scientific advisory board for the PROOF trial, is the deputy principal investigator of the New England Regional Coordinating Center for the for the NINDS Stroke Trials Network (NIH U10-NS086729) and is on the scientific advisory board for the Biogen sponsored ACTION-II clinical trial. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.